Medical Innovation Exchange

Merck’s cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2

https://www.fiercebiotech.com/biotech/mercks-cardiovascular-future-takes-shape-sotatercept-overachieves-and-oral-pcsk9-passes

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!